We recently published 10 Stocks With Massive Gains; 5 at Record Highs. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) was one ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its CEO & President, Najat Khan, Ph.D., will present Tuesday, January 13 ...

On a Tuesday at the end of last semester, I asked my first-year writing class how they were using AI in their courses. One of ...

Peter Krull, director of Earth Equity Advisors, discusses why he's bullish on renewable energy and shares his top clean ...

Especially on X, algorithmic culture is characterized by ceaseless iteration: Everything that’s happening is piled atop all ...

CrowdStrike's 2025 data shows attackers breach AI systems in 51 seconds. Field CISOs reveal how inference security platforms ...

Keep up to date with the most important stories and the best deals, as picked by the PC Gamer team.

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $4.70, marking a -3.29% move from the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.01%.

Machine learning is reshaping the way portfolios are built, monitored, and adjusted. Investors are no longer limited to ...

In addition to being early to the defense tech and AI trends, Lux has realized significant exits from its investment in AI ...